910 related articles for article (PubMed ID: 34985800)
41. sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).
Perales A; Delgado JL; de la Calle M; García-Hernández JA; Escudero AI; Campillos JM; Sarabia MD; Laíz B; Duque M; Navarro M; Calmarza P; Hund M; Álvarez FV;
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):373-382. PubMed ID: 27883242
[TBL] [Abstract][Full Text] [Related]
42. Maternal cardiac function at 19-23 weeks' gestation in prediction of pre-eclampsia.
Gibbone E; Wright A; Vallenas Campos R; Sanchez Sierra A; Nicolaides KH; Charakida M
Ultrasound Obstet Gynecol; 2021 May; 57(5):739-747. PubMed ID: 33294998
[TBL] [Abstract][Full Text] [Related]
43. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
[TBL] [Abstract][Full Text] [Related]
44. The role of the soluble fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PIGF) - ratio in clinical practice in obstetrics: diagnostic and prognostic value.
Melo DCS; Sousa RP; Pais MSJDR; Felix LM; Pinto FF; Moura JPSA
J Perinat Med; 2023 Sep; 51(7):896-903. PubMed ID: 37163520
[TBL] [Abstract][Full Text] [Related]
45. Soluble fms-like tyrosine kinase-1, placental growth factor and their ratio as a predictor for pre-eclampsia in East Asians.
Cheng YKY; Law LW; Leung TY; Chan OK; Sahota DS
Pregnancy Hypertens; 2018 Jan; 11():61-65. PubMed ID: 29523275
[TBL] [Abstract][Full Text] [Related]
46. Impact of Angiogenic and Cardiovascular Biomarkers for Prediction of Placental Dysfunction in the First Trimester of Pregnancy.
Nan MN; García-Osuna Á; Mora J; Trilla C; Antonijuan A; Orantes V; Cruz-Lemini M; Blanco-Vaca F; Llurba E
Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238997
[TBL] [Abstract][Full Text] [Related]
47. Contingent screening in stratification of pregnancy care based on risk of pre-eclampsia at 19-24 weeks' gestation.
Litwinska M; Litwinska E; Bouariu A; Syngelaki A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):553-560. PubMed ID: 34309913
[TBL] [Abstract][Full Text] [Related]
48. The association between placenta-associated circulating biomarkers and composite adverse delivery outcome of a likely placental cause in healthy post-date pregnancies.
Bowe S; Mitlid-Mork B; Georgieva A; Gran JM; Redman CWG; Staff AC; Sugulle M
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1893-1901. PubMed ID: 34212381
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of screening performance of first-trimester competing-risks prediction model for small-for-gestational age in Asian population.
Nguyen-Hoang L; Papastefanou I; Sahota DS; Pooh RK; Zheng M; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Yapan P; Sim WS; Poon LC;
Ultrasound Obstet Gynecol; 2024 Mar; 63(3):331-341. PubMed ID: 37552550
[TBL] [Abstract][Full Text] [Related]
50. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
[TBL] [Abstract][Full Text] [Related]
51. Usefulness of angiogenic factors in prenatal counseling of late-onset fetal growth-restricted and small-for-gestational-age gestations: a prospective observational study.
Hurtado I; Bonacina E; Garcia-Manau P; Serrano B; Armengol-Alsina M; Mendoza M; Maiz N; Carreras E
Arch Gynecol Obstet; 2023 Nov; 308(5):1485-1495. PubMed ID: 36401095
[TBL] [Abstract][Full Text] [Related]
52. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
[TBL] [Abstract][Full Text] [Related]
53. STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35-37 weeks' gestation.
Döbert M; Wright A; Varouxaki AN; Mu AC; Syngelaki A; Rehal A; Delgado JL; Akolekar R; Muscettola G; Janga D; Singh M; Martin-Alonso R; Dütemeyer V; De Alvarado M; Atanasova V; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 Jan; 59(1):69-75. PubMed ID: 34580947
[TBL] [Abstract][Full Text] [Related]
54. The sFlt-1/PlGF ratio values within the <38, 38-85 and >85 brackets as compared to perinatal outcomes.
Bednarek-Jędrzejek M; Kwiatkowski S; Ksel-Hryciów J; Tousty P; Nurek K; Kwiatkowska E; Cymbaluk-Płoska A; Torbé A
J Perinat Med; 2019 Sep; 47(7):732-740. PubMed ID: 31339858
[TBL] [Abstract][Full Text] [Related]
55. The sFlt-1/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes.
Chang YS; Chen CN; Jeng SF; Su YN; Chen CY; Chou HC; Tsao PN; Hsieh WS
Pediatr Neonatol; 2017 Dec; 58(6):529-533. PubMed ID: 28571908
[TBL] [Abstract][Full Text] [Related]
56. Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology.
Romero R; Jung E; Chaiworapongsa T; Erez O; Gudicha DW; Kim YM; Kim JS; Kim B; Kusanovic JP; Gotsch F; Taran AB; Yoon BH; Hassan SS; Hsu CD; Chaemsaithong P; Gomez-Lopez N; Yeo L; Kim CJ; Tarca AL
Am J Obstet Gynecol; 2022 Oct; 227(4):615.e1-615.e25. PubMed ID: 36180175
[TBL] [Abstract][Full Text] [Related]
57. Role of Doppler ultrasound at time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study.
Rizzo G; Mappa I; Bitsadze V; Słodki M; Khizroeva J; Makatsariya A; D'Antonio F
Ultrasound Obstet Gynecol; 2020 Jun; 55(6):793-798. PubMed ID: 31343783
[TBL] [Abstract][Full Text] [Related]
58. Prediction of adverse maternal outcomes of early severe preeclampsia.
Mirkovic L; Tulic I; Stankovic S; Soldatovic I
Pregnancy Hypertens; 2020 Oct; 22():144-150. PubMed ID: 32979729
[TBL] [Abstract][Full Text] [Related]
59. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
60. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
